Table of Contents
Executive Summary
1 Industry Overview of Dopamine Agents
1.1 Definition of Dopamine Agents
1.2 Dopamine Agents Segment by Type
1.2.1 Global Dopamine Agents Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral
1.2.3 Injectable
1.3 Dopamine Agents Segment by Applications
1.3.1 Global Dopamine Agents Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Dopamine Agents Overall Market
1.4.1 Global Dopamine Agents Revenue (2014-2025)
1.4.2 Global Dopamine Agents Production (2014-2025)
1.4.3 North America Dopamine Agents Status and Prospect (2014-2025)
1.4.4 Europe Dopamine Agents Status and Prospect (2014-2025)
1.4.5 China Dopamine Agents Status and Prospect (2014-2025)
1.4.6 Japan Dopamine Agents Status and Prospect (2014-2025)
1.4.7 Southeast Asia Dopamine Agents Status and Prospect (2014-2025)
1.4.8 India Dopamine Agents Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Dopamine Agents
2.3 Manufacturing Process Analysis of Dopamine Agents
2.4 Industry Chain Structure of Dopamine Agents
3 Development and Manufacturing Plants Analysis of Dopamine Agents
3.1 Capacity and Commercial Production Date
3.2 Global Dopamine Agents Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Dopamine Agents
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Dopamine Agents Production and Capacity Analysis
4.2 Dopamine Agents Revenue Analysis
4.3 Dopamine Agents Price Analysis
4.4 Market Concentration Degree
5 Dopamine Agents Regional Market Analysis
5.1 Dopamine Agents Production by Regions
5.1.1 Global Dopamine Agents Production by Regions
5.1.2 Global Dopamine Agents Revenue by Regions
5.2 Dopamine Agents Consumption by Regions
5.3 North America Dopamine Agents Market Analysis
5.3.1 North America Dopamine Agents Production
5.3.2 North America Dopamine Agents Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Dopamine Agents Import and Export
5.4 Europe Dopamine Agents Market Analysis
5.4.1 Europe Dopamine Agents Production
5.4.2 Europe Dopamine Agents Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Dopamine Agents Import and Export
5.5 China Dopamine Agents Market Analysis
5.5.1 China Dopamine Agents Production
5.5.2 China Dopamine Agents Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Dopamine Agents Import and Export
5.6 Japan Dopamine Agents Market Analysis
5.6.1 Japan Dopamine Agents Production
5.6.2 Japan Dopamine Agents Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Dopamine Agents Import and Export
5.7 Southeast Asia Dopamine Agents Market Analysis
5.7.1 Southeast Asia Dopamine Agents Production
5.7.2 Southeast Asia Dopamine Agents Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Dopamine Agents Import and Export
5.8 India Dopamine Agents Market Analysis
5.8.1 India Dopamine Agents Production
5.8.2 India Dopamine Agents Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Dopamine Agents Import and Export
6 Dopamine Agents Segment Market Analysis (by Type)
6.1 Global Dopamine Agents Production by Type
6.2 Global Dopamine Agents Revenue by Type
6.3 Dopamine Agents Price by Type
7 Dopamine Agents Segment Market Analysis (by Application)
7.1 Global Dopamine Agents Consumption by Application
7.2 Global Dopamine Agents Consumption Market Share by Application (2014-2019)
8 Dopamine Agents Major Manufacturers Analysis
8.1 Glaxosmithkline
8.1.1 Glaxosmithkline Dopamine Agents Production Sites and Area Served
8.1.2 Glaxosmithkline Product Introduction, Application and Specification
8.1.3 Glaxosmithkline Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Actavis
8.2.1 Actavis Dopamine Agents Production Sites and Area Served
8.2.2 Actavis Product Introduction, Application and Specification
8.2.3 Actavis Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Eli Lilly
8.3.1 Eli Lilly Dopamine Agents Production Sites and Area Served
8.3.2 Eli Lilly Product Introduction, Application and Specification
8.3.3 Eli Lilly Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sun Pharmaceutical
8.4.1 Sun Pharmaceutical Dopamine Agents Production Sites and Area Served
8.4.2 Sun Pharmaceutical Product Introduction, Application and Specification
8.4.3 Sun Pharmaceutical Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Novartis
8.5.1 Novartis Dopamine Agents Production Sites and Area Served
8.5.2 Novartis Product Introduction, Application and Specification
8.5.3 Novartis Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck
8.6.1 Merck Dopamine Agents Production Sites and Area Served
8.6.2 Merck Product Introduction, Application and Specification
8.6.3 Merck Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Cardinal Health
8.7.1 Cardinal Health Dopamine Agents Production Sites and Area Served
8.7.2 Cardinal Health Product Introduction, Application and Specification
8.7.3 Cardinal Health Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Pfizer
8.8.1 Pfizer Dopamine Agents Production Sites and Area Served
8.8.2 Pfizer Product Introduction, Application and Specification
8.8.3 Pfizer Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Teva
8.9.1 Teva Dopamine Agents Production Sites and Area Served
8.9.2 Teva Product Introduction, Application and Specification
8.9.3 Teva Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Abbott
8.10.1 Abbott Dopamine Agents Production Sites and Area Served
8.10.2 Abbott Product Introduction, Application and Specification
8.10.3 Abbott Dopamine Agents Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Dopamine Agents Market
9.1 Global Dopamine Agents Market Trend Analysis
9.1.1 Global Dopamine Agents Market Size (Volume and Value) Forecast 2019-2025
9.2 Dopamine Agents Regional Market Trend
9.2.1 North America Dopamine Agents Forecast 2019-2025
9.2.2 Europe Dopamine Agents Forecast 2019-2025
9.2.3 China Dopamine Agents Forecast 2019-2025
9.2.4 Japan Dopamine Agents Forecast 2019-2025
9.2.5 Southeast Asia Dopamine Agents Forecast 2019-2025
9.2.6 India Dopamine Agents Forecast 2019-2025
9.3 Dopamine Agents Market Trend (Product Type)
9.4 Dopamine Agents Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Dopamine Agents Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Dopamine Agents
Table Global Dopamine Agents Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Dopamine Agents Production Market Share by Types in 2018
Figure Oral Product Picture
Figure Injectable Product Picture
Table Global Dopamine Agents Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Dopamine Agents Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Global Dopamine Agents Revenue (Million USD) (2014-2025)
Figure Global Dopamine Agents Production (K Units) (2014-2025)
Figure North America Dopamine Agents Market Size (Million USD) (2014-2025)
Figure Europe Dopamine Agents Market Size (Million USD) (2014-2025)
Figure China Dopamine Agents Market Size (Million USD) (2014-2025)
Figure Japan Dopamine Agents Market Size (Million USD) (2014-2025)
Figure Southeast Asia Dopamine Agents Market Size (Million USD) (2014-2025)
Figure India Dopamine Agents Market Size (Million USD) (2014-2025)
Table Dopamine Agents Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Dopamine Agents in 2018
Figure Manufacturing Process Analysis of Dopamine Agents
Figure Industry Chain Structure of Dopamine Agents
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Dopamine Agents Manufacturing Plants Distribution
Table Dopamine Agents Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Dopamine Agents Capacity (K Units) of Major Manufacturers (2014-2019)
Table Dopamine Agents Production (K Units) of Major Manufacturers (2014-2019)
Table Dopamine Agents Production Market Share of Major Manufacturers (2014-2019)
Figure Dopamine Agents Production Share by Manufacturers in 2018
Table Dopamine Agents Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Dopamine Agents Revenue Market Share of Major Manufacturers (2014-2019)
Figure Dopamine Agents Revenue Share by Manufacturers in 2018
Table Dopamine Agents Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Dopamine Agents Production by Regions 2014-2019 (K Units)
Table Global Dopamine Agents Production Market Share by Regions 2014-2019
Figure Global Dopamine Agents Production Market Share by Regions in 2018
Table Global Dopamine Agents Revenue by Regions 2014-2019 (Million USD)
Table Global Dopamine Agents Revenue Market Share by Regions 2014-2019
Figure Global Dopamine Agents Revenue Market Share by Regions in 2018
Table Global Dopamine Agents Consumption by Regions 2014-2019 (K Units)
Table Global Dopamine Agents Consumption Market Share by Regions 2014-2019
Figure North America Dopamine Agents Production Growth Rate 2014-2019 (K Units)
Figure North America Dopamine Agents Revenue Growth Rate 2014-2019 (Million USD)
Table North America Dopamine Agents Production, Consumption Import and Export (K Units)
Figure Europe Dopamine Agents Production Growth Rate 2014-2019 (K Units)
Figure Europe Dopamine Agents Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Dopamine Agents Production, Consumption Import and Export (K Units)
Figure China Dopamine Agents Production Growth Rate 2014-2019 (K Units)
Figure China Dopamine Agents Revenue Growth Rate 2014-2019 (Million USD)
Table China Dopamine Agents Production, Consumption Import and Export (K Units)
Figure Japan Dopamine Agents Production Growth Rate 2014-2019 (K Units)
Figure Japan Dopamine Agents Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Dopamine Agents Production, Consumption Import and Export (K Units)
Figure Southeast Asia Dopamine Agents Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Dopamine Agents Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Dopamine Agents Production, Consumption Import and Export (K Units)
Figure India Dopamine Agents Production Growth Rate 2014-2019 (K Units)
Figure India Dopamine Agents Revenue Growth Rate 2014-2019 (Million USD)
Table India Dopamine Agents Production, Consumption Import and Export (K Units)
Figure Global Consumption Dopamine Agents Market Share by Application (2014-2019)
Figure Global Value (Consumption) Dopamine Agents Market Share by Application (2014-2019)
Table Glaxosmithkline Dopamine Agents Production Sites and Area Served
Table Glaxosmithkline Dopamine Agents Product Introduction, Application and Specification
Table Glaxosmithkline Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Glaxosmithkline Dopamine Agents Production Growth Rate (2014-2019)
Table Glaxosmithkline Dopamine Agents Production Market Share (2014-2019)
Figure Glaxosmithkline Dopamine Agents Revenue Market Share (2014-2019)
Table Glaxosmithkline Dopamine Agents Main Business and Markets Served
Table Actavis Dopamine Agents Production Sites and Area Served
Table Actavis Dopamine Agents Product Introduction, Application and Specification
Table Actavis Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis Dopamine Agents Production Growth Rate (2014-2019)
Table Actavis Dopamine Agents Production Market Share (2014-2019)
Figure Actavis Dopamine Agents Revenue Market Share (2014-2019)
Table Actavis Dopamine Agents Main Business and Markets Served
Table Eli Lilly Dopamine Agents Production Sites and Area Served
Table Eli Lilly Dopamine Agents Product Introduction, Application and Specification
Table Eli Lilly Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Dopamine Agents Production Growth Rate (2014-2019)
Table Eli Lilly Dopamine Agents Production Market Share (2014-2019)
Figure Eli Lilly Dopamine Agents Revenue Market Share (2014-2019)
Table Eli Lilly Dopamine Agents Main Business and Markets Served
Table Sun Pharmaceutical Dopamine Agents Production Sites and Area Served
Table Sun Pharmaceutical Dopamine Agents Product Introduction, Application and Specification
Table Sun Pharmaceutical Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Dopamine Agents Production Growth Rate (2014-2019)
Table Sun Pharmaceutical Dopamine Agents Production Market Share (2014-2019)
Figure Sun Pharmaceutical Dopamine Agents Revenue Market Share (2014-2019)
Table Sun Pharmaceutical Dopamine Agents Main Business and Markets Served
Table Novartis Dopamine Agents Production Sites and Area Served
Table Novartis Dopamine Agents Product Introduction, Application and Specification
Table Novartis Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Dopamine Agents Production Growth Rate (2014-2019)
Table Novartis Dopamine Agents Production Market Share (2014-2019)
Figure Novartis Dopamine Agents Revenue Market Share (2014-2019)
Table Novartis Dopamine Agents Main Business and Markets Served
Table Merck Dopamine Agents Production Sites and Area Served
Table Merck Dopamine Agents Product Introduction, Application and Specification
Table Merck Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Dopamine Agents Production Growth Rate (2014-2019)
Table Merck Dopamine Agents Production Market Share (2014-2019)
Figure Merck Dopamine Agents Revenue Market Share (2014-2019)
Table Merck Dopamine Agents Main Business and Markets Served
Table Cardinal Health Dopamine Agents Production Sites and Area Served
Table Cardinal Health Dopamine Agents Product Introduction, Application and Specification
Table Cardinal Health Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Cardinal Health Dopamine Agents Production Growth Rate (2014-2019)
Table Cardinal Health Dopamine Agents Production Market Share (2014-2019)
Figure Cardinal Health Dopamine Agents Revenue Market Share (2014-2019)
Table Cardinal Health Dopamine Agents Main Business and Markets Served
Table Pfizer Dopamine Agents Production Sites and Area Served
Table Pfizer Dopamine Agents Product Introduction, Application and Specification
Table Pfizer Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Dopamine Agents Production Growth Rate (2014-2019)
Table Pfizer Dopamine Agents Production Market Share (2014-2019)
Figure Pfizer Dopamine Agents Revenue Market Share (2014-2019)
Table Pfizer Dopamine Agents Main Business and Markets Served
Table Teva Dopamine Agents Production Sites and Area Served
Table Teva Dopamine Agents Product Introduction, Application and Specification
Table Teva Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Dopamine Agents Production Growth Rate (2014-2019)
Table Teva Dopamine Agents Production Market Share (2014-2019)
Figure Teva Dopamine Agents Revenue Market Share (2014-2019)
Table Teva Dopamine Agents Main Business and Markets Served
Table Abbott Dopamine Agents Production Sites and Area Served
Table Abbott Dopamine Agents Product Introduction, Application and Specification
Table Abbott Dopamine Agents Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Dopamine Agents Production Growth Rate (2014-2019)
Table Abbott Dopamine Agents Production Market Share (2014-2019)
Figure Abbott Dopamine Agents Revenue Market Share (2014-2019)
Table Abbott Dopamine Agents Main Business and Markets Served
Figure Global Dopamine Agents Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Dopamine Agents Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Dopamine Agents Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Dopamine Agents Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Dopamine Agents Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Dopamine Agents Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Dopamine Agents Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Dopamine Agents Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Dopamine Agents Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Dopamine Agents Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Dopamine Agents Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Dopamine Agents Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Dopamine Agents Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Dopamine Agents Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Dopamine Agents Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Dopamine Agents by Type (2019-2025)
Table Global Consumption (K Units) of Dopamine Agents by Application (2019-2025)
Table Dopamine Agents Distributors List
Table Dopamine Agents Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【掲載企業】
Glaxosmithkline、Actavis、Eli Lilly、Sun Pharmaceutical、Novartis、Merck、Cardinal Health、Pfizer、Teva、Abbott、